Vanguard Personalized Indexing Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Buy
28,717
+14,959
+109% +$102K ﹤0.01% 1768
2025
Q4
$27.2K Buy
13,758
+1,057
+8% +$2.4K ﹤0.01% 1925
2025
Q3
$31.2K Sell
12,701
-2,730
-18% -$7.03K ﹤0.01% 1948
2025
Q2
$40.7K Buy
15,431
+379
+3% +$1.02K ﹤0.01% 1852
2025
Q1
$45.3K Sell
15,052
-1,690
-10% -$5.12K ﹤0.01% 1685
2024
Q4
$42.9K Buy
16,742
+2,806
+20% +$11.7K ﹤0.01% 1711
2024
Q3
$51.8K Sell
13,936
-1,938
-12% -$8.97K ﹤0.01% 1675
2024
Q2
$100K Buy
15,874
+474
+3% +$3.13K ﹤0.01% 1527
2024
Q1
$82.7K Sell
15,400
-1,378
-8% -$6.24K ﹤0.01% 1534
2023
Q4
$84.2K Sell
16,778
-4,828
-22% -$15.1K ﹤0.01% 1486
2023
Q3
$36.5K Buy
+21,606
New +$43.4K ﹤0.01% 1421
2021
Q4
Sell
-15,446
Closed -$150K 1082
2021
Q3
$150K Buy
+15,446
New +$170K 0.01% 943

Other funds holding IBRX